Yael Brenner, Vice President of Quality at Kamada Ltd (NASDAQ:KMDA), filed a Form 4 on September 17, 2026, reporting five net exercises of employee stock options and the resulting changes in beneficial ownership of ordinary shares, all transacted on September 14, 2026.

Key Highlights

  • Five net exercises: Brenner exercised five separate employee stock option grants on September 14, 2026, each carrying an exercise price of $5.93 per share (converted from NIS at the Bank of Israel rate for that date).
  • Options exercised: The five grants covered 5,000, 5,000, 5,000, 6,500, and 5,464 ordinary shares, respectively.
  • Shares received: Net shares received across the five exercises were 1,371, 1,371, 1,371, 1,783, and 1,499 ordinary shares, with withheld shares covering exercise price and tax obligations.
  • Closing price used: The company applied a closing stock price of $8.36 for four exercises and $8.35 for the fifth, pursuant to the 2011 Share Award Plan.
  • Resulting ownership: Following all reported transactions, Brenner directly holds 6,266 ordinary shares, according to the filing.
  • Trustee arrangement: All options were held by a trustee under Kamada's 2011 Share Award Plan, and after exercise, zero derivative securities remain beneficially owned, the filing states.

Kamada VP Quality Nets Ordinary Shares Through Multiple Option Exercises

According to the Form 4 filed with the SEC, Yael Brenner, who serves as Vice President of Quality at Kamada Ltd, a biopharmaceutical company whose ordinary shares trade on NASDAQ:KMDA, exercised five employee stock option grants on September 14, 2026. All five grants carried an exercise price of $5.93 per share, which the filing notes represents a convenience conversion from New Israeli Shekels based on the exchange rate published by the Bank of Israel as of September 14, 2026.

Each exercise was structured as a "net exercise" under the terms of the company's 2011 Share Award Plan. In a net exercise, the company withholds a portion of the underlying shares to cover both the exercise price and applicable tax withholdings, with the reporting person receiving only the remaining net shares. For four of the five exercises, the closing price applied was $8.36 per share; for the fifth, covering 5,464 underlying shares, the closing price applied was $8.35 per share. The filing states that all options had vested in four equal installments of 25% on each of the four anniversaries of the respective grant dates.

Prior to exercise, all five option positions were held indirectly through a trustee under Kamada's 2011 Share Award Plan, as noted in the filing. Following the completion of all reported transactions, Brenner directly holds 6,266 ordinary shares, and no derivative securities remain beneficially owned, according to the disclosure. The filing was signed by Yael Brenner on September 17, 2026.

What Was Disclosed

The filing disclosed five net exercises of employee stock options by Kamada's VP Quality on September 14, 2026, each at an exercise price of $5.93 per share, resulting in direct ownership of 6,266 ordinary shares and zero remaining derivative securities.